Access Tools

Patient Need Assessment Tool

Personalized insights to improve treatment adherence and outcomes.

Overview

Making Adherence Interventions More Effective

Axios’ Patient Needs Assessment Tool (PNAT) identifies the individual factors that may put a patient at risk of poor adherence or treatment discontinuation. Built around the World Health Organization’s (WHO) five dimensions of adherence, PNAT combines qualitative and semi-quantitative assessment to generate personalized insights and inform the most appropriate interventions for each patient.

PNAT Value

What Does PNAT Solve?

PNAT helps identify why individual patients may struggle to stay on treatment, and what can be done about it.

Identifies Individual Adherence Risks

Pinpoints the specific factors that may put a patient at risk of poor adherence or treatment discontinuation.

Personalizes the Intervention

Uses patient-specific insights to determine the interventions most likely to address their individual needs.

Moves Beyond One-Size-Fits-All

Recognizes that patients face different barriers to adherence and require different approaches to overcome them.

Supports Better Adherence and Outcomes

Results are used to develop a personalized plan to target adherence risk factors, helping patients complete their course of treatment and achieve optimal medical outcomes.

By The Numbers

Scelerisque Aliquet Ipsum Dolor Pulvinar.

116+

Countries

10M+

Patients

28+

Years

Adherence isn’t one-size-fits-all. Personalized insights address what matters most to each patient, helping them stay on track with the treatment they need.

Publications

Why pnat

Patient-Centered Approach to Adherence

Better treatment adherence starts with understanding the patient. To ensure program sustainability, PNAT is the starting point for every Axios adherence solution.

PNAT focuses on the individual patient, identifying the specific factors that may influence their ability to stay on treatment.

Axios in Action

Featured Case Study

Improving Adherence to Multiple Sclerosis Treatment

Axios partnered with Saudi healthcare stakeholders to develop a personalized MS adherence program that addressed individual patient barriers, achieving 97% treatment adherence among nearly 600 enrolled patients.

Read More

Tools